BREAST CANCER METASTATIC
Clinical trials for BREAST CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER METASTATIC trials appear
Sign up with your email to follow new studies for BREAST CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo vaccine and immunotherapy tackles Hard-to-Treat breast cancer
Disease control CompletedThis early-phase trial tested a personalized cancer vaccine (SV-BR-1-GM) combined with an immunotherapy drug (retifanlimab) in 36 people with advanced breast cancer that had stopped responding to standard treatments. The vaccine is made from the patient's own tumor cells and aims…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: BriaCell Therapeutics Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill could beat chemo for BRCA breast cancer
Disease control CompletedThis Phase 3 trial compared the pill olaparib to standard chemotherapy in 302 people with metastatic breast cancer who have inherited BRCA1 or BRCA2 mutations. The goal was to see if olaparib could slow cancer growth better than chemo. Participants took olaparib twice daily or re…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo shows promise for aggressive breast cancer
Disease control CompletedThis study tested two treatment plans for people with advanced HR-positive, HER2-negative breast cancer that is aggressive. One group received a drug called abemaciclib plus hormone therapy. The other group started with a short course of chemotherapy, then switched to abemaciclib…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC